The current PE ratio of AHCO cannot be calculated, as the latest EPS of -$5.06 is negative. The most recent PE ratio recorded for AdaptHealth was 40.57 in June 2023.
Over the last six years, the average PE ratio of AdaptHealth has been 30.88. Looking back at the last six years, AHCO's PE ratio peaked in the Sep 2018 quarter at 138.86, with a price of $9.72 and an EPS of $0.07. The Dec 2018 quarter marked the lowest point at 5.04, with a price of $9.83 and an EPS of $1.95.
Maximum annual increase: 87.23% in 2022
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | 40.89 | 87.23% |
| 2021 | 21.84 | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | 5.04 | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| Stock name | PE ratio | Market cap |
|---|---|---|
| NVRO Nevro Corp | N/A | $410.93M |
| OFIX Orthofix Medical Inc | N/A | $508.73M |
| NURO NeuroMetrix Inc | N/A | $8.54M |
| AHCO AdaptHealth Corp | N/A | $1.36B |
The current price to earnings ratio of AHCO cannot be determined, as its EPS of -$5.06 is negative.
Over the last 3 years, the average price to earnings ratio for AHCO stock is 29.18.
Over the last 5 years, the average price to earnings ratio for AHCO stock is 24.46.
The highest quarterly PE ratio in the last six years has been 138.86 and it was in the Sep 2018 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.